1.
Application of PK-PD modeling in pharmacokinetics of Chinese materia medica
PK-PD模型在中药药动学中的应用
2.
Dosage regimen of cefaclor based on pharmacokinetic-pharmacodynamic model
基于PK/PD模型的头孢克洛给药方案
3.
Research of Cyclovirobuxine D and Buxine s PK-PD Binding Model;
环维黄杨星D和黄杨宁PK-PD结合模型研究
4.
PK/PD study of Faropenem with the use of Monte Carlo Simulations
应用蒙特卡洛模拟法的法罗培南PK/PD研究
5.
PhMRI Monitoring of GDNF Treatment and Development of a Early Stage Model of PD;
phMRI监测GDNF对PD的治疗效果与早期PD模型的建立
6.
Pharmacokinetic/pharmacodynamic Research of Vancomycin with Continuous Infusion in Patients with Bacterial Pneumonia
细菌性肺炎患者万古霉素持续静滴的PK/PD研究
7.
Fuzzy Gain PD Type Iterative Learning Control Algorithm and Its Application
模糊增益PD型迭代学习算法及其应用
8.
The Effect of TUM2-PK in MPE Rat Models Serum and bFGF in Their Membrana Pleuralis Treated by Zhu Yin Ⅰ;
逐饮Ⅰ号对恶性胸水大鼠模型血清TUM2-PK和胸膜组织bFGF的影响
9.
Research on Pharmacokinetics/ Pharmacodynamics（PK/PD）and Mechanism of Action of D-polymannuronicate;
D-聚甘酯的药代动力学/药效学（PK/PD）及作用机制的系列研究
10.
Non-clinical Pharmacokinetic and Pharmacodynamic Study of an Oral Insulin Enteric Capsule;
胰岛素肠溶胶囊非临床药代动力学（PK）与药效动力学（PD）研究
11.
Study of PK/PD parameters to predict the ability of levofloxacin to inhibit the resistant mutation of Staphylococcus aureus
PK/PD参数预测左氧氟沙星抑制金黄色葡萄球菌耐药突变的研究
12.
The Effects on Apoptosis of Parkinson s Disease Cell Model by Knock-down Pael-R Gene Expression Through RNAi;
RNA干扰Pael-R基因表达对PD模型细胞凋亡的影响
13.
The changs and significance of Nurr1 and TH expression in the substantia nigra of PD model rats
PD模型大鼠黑质中Nurr1和TH的表达变化及其意义
14.
Effect on TUM2-PK in Serum of MPE Rat Model and bFGF in Its Membrana Pleuralis Treated by Zhu Yin I
逐饮Ⅰ号对恶性胸水大鼠模型血清TUM2-PK含量和胸膜组织bFGF表达的影响
15.
Studies on Compatibility Principles of HED--the Effect of the Different Compatibility Groups on the Effective Components and Pharmacological Response of HE;
麻黄汤组方原理的研究——PK-PD法研究组方对君药麻黄效应成分及药理活性的影响
16.
Study of PK/PD Parameters to Predict the Efficacy and Inhibition of Resistant Mutation of Staphylococcus Aureus Infection
PK/PD参数预测金黄色葡萄球菌感染的疗效和抑制细菌耐药突变的系列研究
17.
Protective Roles of Iptakalim on Parkinsion's Disease Models in Rats via Anti-excitotoxicity Mechansims;
埃他卡林对PD模型鼠保护作用的抗兴奋性神经毒性机制研究
18.
Experimental Study of TAT Mediate EGFP into Mice Tissues and BDNF to Treat PD Model Rat;
TAT介导EGFP在小鼠体内的分布及介导BDNF治疗PD模型鼠的实验研究